Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
New research has found that women with acute respiratory distress syndrome (ARDS) are less likely to be given the right treatment than men.
ARDS is a condition where a person’s lungs can’t provide enough oxygen to the body. This is normally because of another infection or injury affecting the lungs. People with ARDS are normally put on a machine to help them breathe (ventilator) in hospital to help their breathing.
A recent study published in the European Respiratory Journal compared ARDS in men and women. The study found no differences in the diagnosis of ARDS between men and women.
However, the researchers found that women were less likely to be given the right treatment for ARDS. They explained this may be because women are normally shorter than men. This can lead to doctors giving women the wrong setting on a breathing machine. In fact, one of the studies found that shorter women were much less likely to receive the right treatment.
In people with severe ARDS, women were more likely to die in hospital compared to men.
In the past, medical treatment was often based on scientific studies that used white, male subjects only. This has changed recently as many regulatory organisations have said that studies must include females, as well as people of different ethnicities. Researchers are still learning about how this historical bias affects people’s health today.
This research could lead to better care for women with ARDS, if the findings are used to rethink ventilator settings for women in hospitals.
Read a commentary about gender differences in ARDS management
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79